Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Klaus Schöllkopf is active.

Publication


Featured researches published by Klaus Schöllkopf.


Tetrahedron | 1999

7α,15α-Ethano bridged steroids. Synthesis and progesterone receptor interaction

Ursula Egner; Karl-Heinrich Fritzemeier; Wolfgang Halfbrodt; Nikolaus Heinrich; Joachim Kuhnke; Anke Müller-Fahrnow; Günter Neef; Klaus Schöllkopf; Wolfgang Schwede

Abstract The synthesis of 7α,15α-ethano bridged steroids is described. Diels-Alder reaction of 3-methoxyestra-1,3,5(10),7,14-pentaen-17-one 4 with ethylene under high pressure provides efficient synthetic access to this class of steroids. Compounds 15 and 17 were tested for their binding affinities to the progesterone receptor (PR). Two low energy conformations 17a and 17b could be identified by force field calculations of compound 17. Both conformations were analysed in complex with the ligand binding domain of the human progesterone receptor (hPR LBD).


Steroids | 1998

Synthesis and Biological Activity of 11,19-Bridged Progestins

Wolfgang Schwede; Karl-Heinrich Fritzemeier; Wolfgang Halfbrodt; Rolf Krattenmacher; Peter Muhn; Günter Neef; Eckhard Ottow; Klaus Schöllkopf

A synthetic approach to 11,19-bridged progestins is described. The key step in the synthesis is a 6-endo-trig radical cyclisation. The new progestins were tested for their biological activities in vitro and in vivo and compared to those of known progestins.


Archive | 1998

Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity

Manfred Lehmann; Klaus Schöllkopf; Peter Strehlke; Nikolaus Heinrich; Karl-Heinrich Fritzemeier; Hans-Peter Muhn; Rolf Krattenmacher


Archive | 1991

New benzimidazole derivatives, method for preparing them and their pharmaceutical use

Rudolf Albrecht; Manfred Lehmann; Klaus Schöllkopf; Rolf Beckmann; Hermann Graf


Archive | 1994

Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments

Wolfgang Schwede; Wolfgang Halfbrodt; Günter Neef; Eckhard Ottow; Klaus Schöllkopf; Rolf Krattenmacher; Karl-Heinrich Fritzemeier


Archive | 1985

NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS

Klaus Schöllkopf; Rudolf Albrecht; Manfred Lehmann; Gertrud Schröder


Archive | 1995

14ALPHA,17ALPHA-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES

Karl-Heinrich Fritzemeier; Wolfgang Halfbrodt; Rolf Krattenmacher; Joachim Kuhnke; Hans-Peter Muhn; Klaus Schöllkopf; Wolfgang Schwede


Archive | 2000

GESTAGEN-GESTAGEN NON-STEROIDAL

Manfred Lehmann; Klaus Schöllkopf; Peter Strehlke; Nikolaus Heinrich; Heinrich Fritzemeier Karl; Peter Muhn Hans; Rolf Krattenmacher


Steroids | 1998

Synthesis and Biological Activity of 11,19-Bridged Progestins 1 1 This paper is dedicated to Prof. R

Wolfgang Schwede; Karl-Heinrich Fritzemeier; Wolfgang Halfbrodt; Rolf Krattenmacher; Peter Muhn; Günter Neef; Eckhard Ottow; Klaus Schöllkopf


Archive | 1998

14-α,17-α-C2 -bridged norprogesterone derivatives

Klaus Schöllkopf; Wolfgang Halfbrodt; Joachim Kuhnke; Wolfgang Schwede; Karl-Heinrich Fritzemeier; Rolf Krattenmacher; Hans-Peter Muhn

Collaboration


Dive into the Klaus Schöllkopf's collaboration.

Researchain Logo
Decentralizing Knowledge